Formed in November 2004, Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors.
Its mission is to cut through the increasing mass of market data and discover the real value of information allowing clients to deliver results more quickly than the competition.
Cello is structured as a professional partnership and operates internationally. We support our growing number of global client account teams with professional hubs in the UK and USA.
Cello combines a cohort of specialist client facing brands with integrated client solutions capability.
Cello is listed on London's AIM (ticker: CLL)